Talgan

Talgan

budesonide

Manufacturer:

Genetic S.p.A

Distributor:

Averroes Pharma
Concise Prescribing Info
Contents
Budesonide
Indications/Uses
Dosage/Direction for Use
Adult 1-2 mg bd. Maintenance: 0.5-1 mg bd. Childn 0.5-1 mg bd. Maintenance: 0.25-0.5 mg bd.
Contraindications
Special Precautions
Not intended for rapid relief & sole therapy of acute asthma episodes. Patients w/ pulmonary TB & viral airway infections. Paradoxical bronchospasm; Cushing's syndrome, Cushingoid features, adrenal suppression, decreased bone mineral density, cataract, glaucoma. Transferring from oral corticosteroid to inhalation soln. Avoid abrupt discontinuation. Prolonged use w/ high doses. Avoid concomitant use w/ ketoconazole, itraconazole or other potent CYP3A4 inhibitors. Reduced hepatic function. Pregnancy. Growth retardation in childn & adolescents.
Adverse Reactions
Oropharyngeal candidiasis; hoarseness, cough, throat irritation; oral mucosal irritation, difficulty swallowing.
Drug Interactions
Increased risk of systemic exposure by potent CYP3A4 inhibitors eg, ketoconazole, itraconazole. Raised plasma conc & enhanced effects w/ oestrogen & contraceptive steroids. False results in ACTH stimulation test.
ATC Classification
R03BA02 - budesonide ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, glucocorticoids.
Presentation/Packing
Form
Talgan inhalation soln 0.5 mg/mL
Packing/Price
2 mL x 20 × 1's
Form
Talgan inhalation soln 0.25 mg/mL
Packing/Price
2 mL x 20 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in